Log in to your Inderes Free account to see all free content on this page.

Duearity

Less than 1K followers

All

Research

Press releases

ShowingAll content types

Press release3/10/2024, 12:43 PM

Duearity has entered into an agreement with a national distributor in the USA

Press release2/6/2024, 7:53 AM

Clinics in the US can now purchase Tinearity G1 through a national trading platform

Eminova Partners day - Duearity

Video1/15/2024, 11:34 AM by

Lucas Mattsson, Jesper Hagman

Eminova Partners day - Duearity

During the day with Eminova Partners, analyst Lucas Mattsson got the chance to interview Fredrik Westman, CEO of Duearity. The discussion includes Duearity as an investment, what the market looks like today and what the strategy for Duearity looks like in the future.

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release12/20/2023, 7:50 AM

Duearity's sales SEK 450,000 in December - the best month so far

Regulatory press release10/2/2023, 9:11 AM

Duearity AB has signed a distributor agreement - covering Belgium, the Netherlands and Luxembourg

Press release8/25/2023, 8:29 AM

Duearity Americas Inc has signed agreements with the first clinics in the United States

Regulatory press release7/27/2023, 8:22 AM

Duearity AB has signed a distributor agreement in Great Britain

Press release6/5/2023, 6:00 AM

Positive results from Duearity's user study on people with tinnitus

Regulatory press release5/23/2023, 9:01 AM

Duearity AB has signed a distributor agreement

Regulatory press release4/26/2023, 12:52 PM

The tinnitus product Tinearity G1 has received market approval in the UK

Regulatory press release10/31/2022, 7:27 AM

Duearity will submit an application for approval of a tinnitus product in the United States

Regulatory press release11/2/2021, 7:41 AM

Duearity to develop AI solution for people suffering from tinnitus

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.